Regulation News
Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.
Visa Shares Drop on Legal Fee Disclosure, Stock Exchange Plan
Visa shares declined 3.1% Friday following a regulatory disclosure that ties a proposed Class B stock exchange to a significant reduction in legal interchange fees. The company estimates those fees at $39.4 billion as of October 2025.
Ex-CEO Gets 20 Years for $200M Bitcoin Ponzi Scheme
Former Praetorian Group International CEO Ramil Palafox received a 20-year prison sentence for orchestrating a $200 million Bitcoin Ponzi scheme that defrauded investors worldwide.
Lilly Builds $1.5B Obesity Pill Inventory Ahead of Key FDA Decision
Eli Lilly shares gained as the pharmaceutical giant disclosed a $1.5 billion inventory build for its experimental oral obesity treatment ahead of an anticipated FDA decision in April.
Philip Morris Hits 52-Week High Despite India IQOS Ban
Philip Morris shares climbed 1.4% to $188.95, setting a new 52-week high. The gain came despite India's health ministry refusing to relax its ban on heated tobacco, blocking the IQOS launch.
Amazon Shares Dip Amid Italian Tax Investigation, AI Spending Concerns Weigh
Amazon stock declined following reports of a new Italian tax probe, extending a sharp February sell-off. Investor focus remains on the company's massive planned AI investments and competitive pressures.
Snap Shares Edge Up in Premarket Amid Texas Lawsuit and Insider Sale
Snap stock rose 0.3% premarket following a 4.6% decline, as Texas sues over child safety allegations and co-founder files to sell 1 million shares. Analyst firm Arete upgraded the stock to Buy.
Applied Materials Settles $252M China Export Case, Shares Dip Ahead of Earnings
Applied Materials shares edged lower premarket after agreeing to a $252.5 million settlement over unauthorized chip equipment exports to China. The company reports quarterly results after the close.
NovoCure Shares Surge on FDA Approval for Pancreatic Cancer Device
NovoCure's stock jumped over 20% premarket after the FDA cleared its Optune Pax device for treating locally advanced pancreatic cancer, marking the first new treatment for this condition in nearly three decades.
IRS Direct Deposit Errors Could Delay 2026 Tax Refunds, Agency Warns
The IRS cautions that incorrect bank details may freeze refunds this filing season, urging taxpayers to verify information and use electronic tools for faster processing.
Lockheed Martin Shares Hold Steady Amid Pentagon Contractor Review
Lockheed Martin shares traded near $630 as the Pentagon initiates an extended review of major defense contractors, potentially impacting shareholder returns. CEO and CFO are scheduled to speak at a Citi conference next week.
Hims & Hers Shares Stabilize After Novo Nordisk Patent Lawsuit Rattles Weight-Loss Strategy
Hims & Hers stock edged up 0.1% premarket following steep declines after Novo Nordisk filed a patent lawsuit over compounded semaglutide. Investors await court developments, FDA signals, and the company's Feb. 23 earnings.